NCT06885333View on ClinicalTrials.gov

Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma

CompletedOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions
GliomaGlioma : Oligodendroglioma or Astrocytoma
All Listed Sponsors
lead

West China Hospital

OTHER

NCT06885333 - Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma | Biotech Hunter | Biotech Hunter